Immuron
IMRN
7 hedge funds and large institutions have $102K invested in Immuron in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
664% more capital invested
Capital invested by funds: $13.3K → $102K (+$88.3K)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
75% more funds holding
Funds holding: 4 → 7 (+3)
0.57% more ownership
Funds ownership: 0.12% → 0.69% (+0.57%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$51.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$23.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.31K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$2.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.1K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.58K |
| 3 |
GWMIA
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
|
-$188 |
IMRN Hedge Fund Activity: Q1 2024 in Review
7 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q1 2024, worth a combined $102K — up 664% from $13.3K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IMRN positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $51.3K. The largest seller was Morgan Stanley, cutting an estimated $7.1K.
- 7 institutional investors held Immuron (IMRN) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $102K of Immuron stock for Q1 2024, up 664% quarter-over-quarter.
- 4 funds opened new Immuron positions in Q1 2024 and 1 closed out, a net change of +3 holders.
- The largest Immuron buyer in Q1 2024 was HRT Financial, an estimated $51.3K added.
- The largest Immuron seller in Q1 2024 was Morgan Stanley, an estimated $7.1K sold.
Based on aggregated 13F filings for Q1 2024.